Related Experiment Video
Updated: Jun 13, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[Renal effects of combined anti-hypertensive treatments]
Maurizio Gallieni1, Laura Olivi, Nicoletta Mezzina
1UO Nefrologia e Dialisi, Ospedale San Carlo Borromeo, Milano. gallieni.maurizio@sancarlo.mi.it
Abstract:
ACE inhibitors and angiotensin receptor blockers confer renal protection in proteinuric nephropaties, but recently worsening of renal outcomes has been reported in non-proteinuric patients treated with a combination of ramipril and telmisartan, compared to ramipril only. In view of these apparently contradictory data, the review wants to shed light on treatment modalities of patients with hypertension and chronic kidney disease.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Action of β1 Blockers
